Inhalation therapy in cystic fibrosis

Vincenzo Carnovale, P. Iacotucci, M. Cellurale, M. D'ippolito, S. Buonaurio, A. Celardo, N. Ferrara

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

In Cystic Fibrosis (CF) inhalation of drugs to treat lung disease has been proven to be highly effective. An increasing number of drugs and devices have been developed for CF lung disease. In this article we will review the current status of inhaled medication in CF, including the various drugs, their modes of administration and indications, and their effects. We will address antibiotics, mucolytics/mucous mobilizers, antiinflammatory drugs, bronchodilators and combinations of solutions. We will review the current knowledge on devices for inhalation therapy with regard to optimal particle sizes and characteristics of wet nebulisers, dry powder and metered dose inhalers. (www.actabiomedica.it).

Original languageEnglish
Pages (from-to)7-9
Number of pages3
JournalActa Biomedica
Volume85
Publication statusPublished - 2014

Fingerprint

Respiratory Therapy
Cystic Fibrosis
Lung Diseases
Inhalation Administration
Expectorants
Metered Dose Inhalers
Equipment and Supplies
Nebulizers and Vaporizers
Bronchodilator Agents
Drug Combinations
Particle Size
Pharmaceutical Preparations
Powders
Anti-Inflammatory Agents
Anti-Bacterial Agents

Keywords

  • Cystic fibrosis
  • Inhalation devices
  • Inhaled medication

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Carnovale, V., Iacotucci, P., Cellurale, M., D'ippolito, M., Buonaurio, S., Celardo, A., & Ferrara, N. (2014). Inhalation therapy in cystic fibrosis. Acta Biomedica, 85, 7-9.

Inhalation therapy in cystic fibrosis. / Carnovale, Vincenzo; Iacotucci, P.; Cellurale, M.; D'ippolito, M.; Buonaurio, S.; Celardo, A.; Ferrara, N.

In: Acta Biomedica, Vol. 85, 2014, p. 7-9.

Research output: Contribution to journalArticle

Carnovale, V, Iacotucci, P, Cellurale, M, D'ippolito, M, Buonaurio, S, Celardo, A & Ferrara, N 2014, 'Inhalation therapy in cystic fibrosis', Acta Biomedica, vol. 85, pp. 7-9.
Carnovale V, Iacotucci P, Cellurale M, D'ippolito M, Buonaurio S, Celardo A et al. Inhalation therapy in cystic fibrosis. Acta Biomedica. 2014;85:7-9.
Carnovale, Vincenzo ; Iacotucci, P. ; Cellurale, M. ; D'ippolito, M. ; Buonaurio, S. ; Celardo, A. ; Ferrara, N. / Inhalation therapy in cystic fibrosis. In: Acta Biomedica. 2014 ; Vol. 85. pp. 7-9.
@article{c62100aea7c24312a6db76f315bcf1fd,
title = "Inhalation therapy in cystic fibrosis",
abstract = "In Cystic Fibrosis (CF) inhalation of drugs to treat lung disease has been proven to be highly effective. An increasing number of drugs and devices have been developed for CF lung disease. In this article we will review the current status of inhaled medication in CF, including the various drugs, their modes of administration and indications, and their effects. We will address antibiotics, mucolytics/mucous mobilizers, antiinflammatory drugs, bronchodilators and combinations of solutions. We will review the current knowledge on devices for inhalation therapy with regard to optimal particle sizes and characteristics of wet nebulisers, dry powder and metered dose inhalers. (www.actabiomedica.it).",
keywords = "Cystic fibrosis, Inhalation devices, Inhaled medication",
author = "Vincenzo Carnovale and P. Iacotucci and M. Cellurale and M. D'ippolito and S. Buonaurio and A. Celardo and N. Ferrara",
year = "2014",
language = "English",
volume = "85",
pages = "7--9",
journal = "Acta Biomedica de l'Ateneo Parmense",
issn = "0392-4203",
publisher = "L'Ateneo Parmense",

}

TY - JOUR

T1 - Inhalation therapy in cystic fibrosis

AU - Carnovale, Vincenzo

AU - Iacotucci, P.

AU - Cellurale, M.

AU - D'ippolito, M.

AU - Buonaurio, S.

AU - Celardo, A.

AU - Ferrara, N.

PY - 2014

Y1 - 2014

N2 - In Cystic Fibrosis (CF) inhalation of drugs to treat lung disease has been proven to be highly effective. An increasing number of drugs and devices have been developed for CF lung disease. In this article we will review the current status of inhaled medication in CF, including the various drugs, their modes of administration and indications, and their effects. We will address antibiotics, mucolytics/mucous mobilizers, antiinflammatory drugs, bronchodilators and combinations of solutions. We will review the current knowledge on devices for inhalation therapy with regard to optimal particle sizes and characteristics of wet nebulisers, dry powder and metered dose inhalers. (www.actabiomedica.it).

AB - In Cystic Fibrosis (CF) inhalation of drugs to treat lung disease has been proven to be highly effective. An increasing number of drugs and devices have been developed for CF lung disease. In this article we will review the current status of inhaled medication in CF, including the various drugs, their modes of administration and indications, and their effects. We will address antibiotics, mucolytics/mucous mobilizers, antiinflammatory drugs, bronchodilators and combinations of solutions. We will review the current knowledge on devices for inhalation therapy with regard to optimal particle sizes and characteristics of wet nebulisers, dry powder and metered dose inhalers. (www.actabiomedica.it).

KW - Cystic fibrosis

KW - Inhalation devices

KW - Inhaled medication

UR - http://www.scopus.com/inward/record.url?scp=84942255757&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942255757&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84942255757

VL - 85

SP - 7

EP - 9

JO - Acta Biomedica de l'Ateneo Parmense

JF - Acta Biomedica de l'Ateneo Parmense

SN - 0392-4203

ER -